Iron-dextran 98%
1 Inquiries
9004-66-4
Pharmaceutical Grade
98%
TIANJIN
25kg/2kg Cardboard Drum
2017-02-16
Iron-dextran
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceLight to dark brown powder. Colloidal suspension of an iron-dextran complex in water. pH 5.2-6.5.
Iron dextran is a dark reddish-brown liquid. Colloidal suspension of an iron-dextran complex in water. pH 5.2-6.5.
Iron dextran is a dark reddish-brown liquid. Colloidal suspension of an iron-dextran complex in water. pH 5.2-6.5.|A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292)Basic Info-
Product Name:
Iron dextran
Other Name:Iron dextran;Imferon;Iron-dextran complex;Iron dextran injection;Ferric dextran;Iro-jex;Chinofer;Imposil;A 100;Myofer 100;Prolongal;Ferroglukin 75;Ferrodextran;Dextrofer 75;Ferdex 100;A 100 (pharmaceutical);B 75;Ferridextran;Fe-dextran;Polyfer;Ferroglucin;Ferroglukin;Dextrofer 100;Proferedex;B 75 (pharmaceutical);Dextran magnetite;Dextran-iron oxide;SHU 555;Dexferrum;Dexfer;Nonemic;Impheron;Idofer;Hyferdex;Dextran iron complex;Fenate;Ironorm;INFeD;Kemofei;CosmoFer;Ferrodex 100;Ferranimal 75;Ferranimal 75M;Iron-GARD;Ferran 100;Ferristat;Infufer;8012-47-3;8050-93-9;9009-88-5;9044-58-0;9061-47-6;11129-47-8;37318-94-8;37349-14-7;50643-00-0;53858-58-5
CAS No.:9004-66-4
InChIKeys:MVZXTUSAYBWAAM-UHFFFAOYSA-N
Molecular Weight:153.917
Exact Mass:1346.576050
EC Number:618-390-1
NSC Number:146177|57631
DSSTox ID:DTXSID1031464
Color/Form:Dark brown, slightly viscous solution
Categories:
Characteristics-
PSA:
83
XLogP3:0.00000
Appearance:solution
Flash Point:greater than 200° F (NTP, 1992)
Water Solubility:H2O: soluble ;Completely miscible with 0.9% sodium chloride injection.
Storage Conditions:Conditions for safe storage, including any incompatibilities: Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and kept upright to prevent leakage.
Toxicity:LD50 i.v. in mice: 2240 mg Fe/kg (Beliles)
PH:pH = 5.2-6.5
Experimental Properties:Dark-brown colloidal solution in saline
Air and Water Reactions:No rapid reaction with air. No rapid reaction with water.
Reactive Group:Non-Redox-Active Inorganic Compounds
Reactivity Profile:IRON DEXTRAN is unstable at a pH of 5 and decomposes at 149-158° F. It may be sensitive to prolonged exposure to air. (NTP, 1992)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Eye irritation, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H319 Causes serious eye irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Iron-dextran
-
Location:
Hongyuan Road 25 Xiqing economical development Tianjin
-
Payment Terms:
D/P,L/C
-
Average lead Time:
60
-
Total Annual Revenue:
Less than $1 million
Tianjin Huairen Pharmaceutical Co., Ltd. was founded in 2002 and is located in Xiqing Economic Development Zone of Tianjin. It is a modern pharmaceutical enterprise integrating scientific research, production and sales. It is now a high-tech pharmaceutical enterprise and technology recognized by Tianjin Science and Technology Commission. Small and medium-sized enterprises. There are 6 shareholders including Haina Sunshine (Beijing) Pharmaceutical Holdings Co., Ltd., Tianjin Science and Technology Investment Group Co., Ltd., Institute of Hematology, Chinese Academy of Medical Sciences. Since its establishment, the company has been adhering to the business philosophy of "quality first, reputation first". In the past years, the market sampling inspection rate has reached 100%, and it has been praised by the Tianjin Market and Quality Supervision and Administration Commission as "A-level enterprise for quantitative production and classification management of pharmaceutical production" and "Reassuring Pharmaceutical Factory" for many consecutive years. In 2014, it successfully passed the new version of GMP certification.
Since its development, the company has mainly produced APIs, tablets, capsules, granules and other dosage forms. There are more than 10 products including gliclazide sustained-release tablets, iron dextran tablets, iron dextran raw materials, telmisartan tablets, simvastatin tablets, irbesartan hydrochlorothiazide dispersible tablets and so on. Among them, dextran iron tablets have the advantages of self-produced raw materials and multiple specifications among similar domestic manufacturers. Sales have steadily increased and are in the forefront for ten years. Telmisartan tablets are currently the company's largest-selling products. Over the years, they have accumulated loyal drug users and have performed well among pharmaceutical companies of the same size.
In order to achieve faster and better development of the company, Huairen Pharmaceutical is committed to introducing strong strategic investors. In 2013, Haina Sunshine successfully invested in the company and became the largest shareholder of Huairen Company through equity transfer in early 2018. The restructured Huairen Company will integrate resources, strengthen technological and management innovation, break through bottlenecks, and achieve steady development of the enterprise. -
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Thailand
Iron drextran
1 KG Aug 20, 2024 Post an enquiry for this product
